Healthcare · Medical - Diagnostics & Research · Market cap $432M · $25.44 · 52-week range $8.20–$27.24
Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-08-25 | Rosin Brian J | officer: CFO of IM8 (US) LLC | 5,100 | $22.80 | $116,280 | SEC Form 4 |
| 2026-08-24 | Rosin Brian J | officer: CFO of IM8 (US) LLC | 18,000 | $21.19 | $381,420 | SEC Form 4 |
| 2026-08-24 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | 11,181 | $21.40 | $239,273 | SEC Form 4 |
| 2026-08-24 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | 6,000 | $20.90 | $125,400 | SEC Form 4 |
| 2026-08-20 | Yeung Danny Sheng Wu | director, officer: Chief Executive Officer | 7,500 | $18.31 | $137,325 | SEC Form 4 |
Last updated September 08, 2026.
ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.